| 001 | 119320 | ||
| 005 | 20240228145432.0 | ||
| 024 | 7 | _ | |a 10.1007/s00415-016-8353-3 |2 doi |
| 024 | 7 | _ | |a pmid:27909801 |2 pmid |
| 024 | 7 | _ | |a 0012-1037 |2 ISSN |
| 024 | 7 | _ | |a 0340-5354 |2 ISSN |
| 024 | 7 | _ | |a 0939-1517 |2 ISSN |
| 024 | 7 | _ | |a 1432-1459 |2 ISSN |
| 024 | 7 | _ | |a 1619-800X |2 ISSN |
| 037 | _ | _ | |a DKFZ-2017-00075 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Breckwoldt, Michael O |0 http://orcid.org/0000-0002-9980-2390 |b 0 |e First author |
| 245 | _ | _ | |a Increasing the sensitivity of MRI for the detection of multiple sclerosis lesions by long axial coverage of the spinal cord: a prospective study in 119 patients. |
| 260 | _ | _ | |a Berlin |c 2017 |b Springer59671 |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2016-12-01 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2017-02-01 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2017-02-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1533813378_16775 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Diagnostic imaging criteria of multiple sclerosis (MS) include the spatial and temporal dissemination of cerebral and/or spinal cord lesions. Magnetic resonance imaging (MRI) is the method of choice for initial diagnosis and follow-up disease monitoring. Current guidelines for spinal MRI recommend sagittal imaging of the spinal cord and lesion confirmation on axial planes if lesions are detected. Sagittal imaging is, however, hampered by technical (e.g. partial volume effects, motion artifacts) and anatomical (e.g. scoliosis) limitations. We hypothesized that long coverage of the spinal cord by axial image acquisition has superior diagnostic performance compared to sagittal imaging and can identify otherwise undetected lesions. Our prospective clinical study included 119 MS patients. Axial MRI revealed ~2.5-fold more lesions than the sagittal angulation (axial lesion load: 4.0 ± 2.4 vs. 1.6 ± 1.2 lesions on sagittal planes, p < 0.001). Importantly, 20 patients (17%) with normal sagittal MRI scans had unequivocal lesions only visible on axial planes (mean lesion number on axial planes in these patients: 2.0 ± 1.3). Moreover, 45 patients (38%) showed a discrepancy of ≥3 lesions that were found additionally on axial scans (mean difference 4.4 ± 1.7). Additionally identified lesions were on average smaller in size and located more laterally within the spinal cord. No lesion on sagittal images was missed on the axial angulation. Our study demonstrates that imaging of small axial segments for lesion confirmation is insufficient in spinal imaging. We recommend implementing a long coverage axial MRI sequence for spinal imaging of MS patients. |
| 536 | _ | _ | |a 317 - Translational cancer research (POF3-317) |0 G:(DE-HGF)POF3-317 |c POF3-317 |f POF III |x 0 |
| 542 | _ | _ | |i 2016-12-01 |2 Crossref |u http://www.springer.com/tdm |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Gradl, Johann |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Hähnel, Stefan |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Hielscher, Thomas |0 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f |b 3 |u dkfz |
| 700 | 1 | _ | |a Wildemann, Brigitte |0 P:(DE-HGF)0 |b 4 |
| 700 | 1 | _ | |a Diem, Ricarda |0 P:(DE-He78)0b1c40947becd495c5aa9778ef098ef4 |b 5 |u dkfz |
| 700 | 1 | _ | |a Platten, Michael |0 P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5 |b 6 |u dkfz |
| 700 | 1 | _ | |a Wick, Wolfgang |0 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee |b 7 |u dkfz |
| 700 | 1 | _ | |a Heiland, Sabine |b 8 |
| 700 | 1 | _ | |a Bendszus, Martin |b 9 |
| 773 | 1 | 8 | |a 10.1007/s00415-016-8353-3 |b Springer Science and Business Media LLC |d 2016-12-01 |n 2 |p 341-349 |3 journal-article |2 Crossref |t Journal of Neurology |v 264 |y 2016 |x 0340-5354 |
| 773 | _ | _ | |a 10.1007/s00415-016-8353-3 |g Vol. 264, no. 2, p. 341 - 349 |0 PERI:(DE-600)1421299-7 |n 2 |p 341-349 |t Journal of neurology |v 264 |y 2016 |x 0340-5354 |
| 909 | C | O | |p VDB |o oai:inrepo02.dkfz.de:119320 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 3 |6 P:(DE-He78)743a4a82daab55306a2c88b9f6bf8c2f |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 4 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 5 |6 P:(DE-He78)0b1c40947becd495c5aa9778ef098ef4 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)5ef8651b0f857b9c640aa5b1498c43b5 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)92e9783ca7025f36ce14e12cd348d2ee |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-317 |2 G:(DE-HGF)POF3-300 |v Translational cancer research |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b J NEUROL : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-He78)G370-20160331 |k G370 |l KKE Neuroonkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)G160-20160331 |k G160 |l Neuroimmunologie und Hirntumorimmunologie |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)C060-20160331 |k C060 |l Biostatistik |x 2 |
| 920 | 1 | _ | |0 I:(DE-He78)L101-20160331 |k L101 |l DKTK Heidelberg |x 3 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)G370-20160331 |
| 980 | _ | _ | |a I:(DE-He78)G160-20160331 |
| 980 | _ | _ | |a I:(DE-He78)C060-20160331 |
| 980 | _ | _ | |a I:(DE-He78)L101-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1056/NEJMra052130 |9 -- missing cx lookup -- |1 EM Frohman |p 942 - |2 Crossref |u Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis-the plaque and its pathogenesis. N Engl J Med 354:942–955 |t N Engl J Med |v 354 |y 2006 |
| 999 | C | 5 | |a 10.1146/annurev.neuro.30.051606.094313 |9 -- missing cx lookup -- |1 BD Trapp |p 247 - |2 Crossref |u Trapp BD, Nave K-A (2008) Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci 31:247–269 |t Annu Rev Neurosci |v 31 |y 2008 |
| 999 | C | 5 | |a 10.1093/brain/121.4.687 |9 -- missing cx lookup -- |1 GJ Nijeholt |p 687 - |2 Crossref |u Nijeholt GJ, van Walderveen MA, Castelijns JA et al (1998) Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain 121:687–697 |t Brain |v 121 |y 1998 |
| 999 | C | 5 | |a 10.1148/radiol.13122566 |9 -- missing cx lookup -- |1 C Lukas |p 542 - |2 Crossref |u Lukas C, Sombekke MH, Bellenberg B et al (2013) Relevance of spinal cord abnormalities to clinical disability in multiple sclerosis: MR imaging findings in a large cohort of patients. Radiology 269:542–552 |t Radiology |v 269 |y 2013 |
| 999 | C | 5 | |a 10.1056/NEJM200009283431307 |9 -- missing cx lookup -- |1 JH Noseworthy |p 938 - |2 Crossref |u Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938–952 |t N Engl J Med |v 343 |y 2000 |
| 999 | C | 5 | |a 10.3174/ajnr.A4539 |9 -- missing cx lookup -- |1 A Traboulsee |p 394 - |2 Crossref |u Traboulsee A, Simon JH, Stone L et al (2016) Revised Recommendations of the Consortium of MS Centers Task Force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. Am J Neuroradiol 37:394–401 |t Am J Neuroradiol |v 37 |y 2016 |
| 999 | C | 5 | |a 10.1038/nrneurol.2015.157 |9 -- missing cx lookup -- |1 MP Wattjes |p 597 - |2 Crossref |u Wattjes MP, Rovira À, Miller D et al (2015) MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients. Nat Rev Neurol 11:597–606 |t Nat Rev Neurol |v 11 |y 2015 |
| 999 | C | 5 | |a 10.1016/S1474-4422(15)00393-2 |9 -- missing cx lookup -- |1 M Filippi |p 292 - |2 Crossref |u Filippi M, Rocca MA, Ciccarelli O et al (2016) MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol 15:292–303 |t Lancet Neurol |v 15 |y 2016 |
| 999 | C | 5 | |a 10.1097/WCO.0000000000000095 |9 -- missing cx lookup -- |1 M Filippi |p 290 - |2 Crossref |u Filippi M, Preziosa P, Rocca MA (2014) Magnetic resonance outcome measures in multiple sclerosis trials. Curr Opin Neurol 27:290–299 |t Curr Opin Neurol |v 27 |y 2014 |
| 999 | C | 5 | |a 10.1136/practneurol-2014-000857 |9 -- missing cx lookup -- |1 S Renowden |p 231 - |2 Crossref |u Renowden S (2014) Imaging in multiple sclerosis and related disorders. Pract Neurol 14:231–241 |t Pract Neurol |v 14 |y 2014 |
| 999 | C | 5 | |a 10.1007/s00062-015-0430-y |9 -- missing cx lookup -- |1 MP Wattjes |p 157 - |2 Crossref |u Wattjes MP, Steenwijk MD, Stangel M (2015) MRI in the diagnosis and monitoring of multiple sclerosis: an update. Clin Neuroradiol 25:157–165 |t Clin Neuroradiol |v 25 |y 2015 |
| 999 | C | 5 | |a 10.1038/nrneurol.2015.80 |9 -- missing cx lookup -- |1 H Kearney |p 327 - |2 Crossref |u Kearney H, Miller DH, Ciccarelli O (2015) Spinal cord MRI in multiple sclerosis—diagnostic, prognostic and clinical value. Nat Rev Neurol 11:327–338 |t Nat Rev Neurol |v 11 |y 2015 |
| 999 | C | 5 | |a 10.1016/S1474-4422(07)70176-X |9 -- missing cx lookup -- |1 JK Swanton |p 677 - |2 Crossref |u Swanton JK, Rovira À, Tintoré M et al (2007) MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 6:677–686 |t Lancet Neurol |v 6 |y 2007 |
| 999 | C | 5 | |a 10.3174/ajnr.A4638 |9 -- missing cx lookup -- |1 S Galler |p 963 - |2 Crossref |u Galler S, Stellmann JP, Young KL et al (2016) Improved lesion detection by using axial T2-weighted MRI with full spinal cord coverage in multiple sclerosis. Am J Neuroradiol 37:963–969 |t Am J Neuroradiol |v 37 |y 2016 |
| 999 | C | 5 | |a 10.1212/WNL.43.12.2632 |9 -- missing cx lookup -- |1 D Kidd |p 2632 - |2 Crossref |u Kidd D, Thorpe JW, Thompson AJ et al (1993) Spinal cord MRI using multi-array coils and fast spin echo II. Findings in multiple sclerosis. Neurology 43:2632–2637 |t Neurology |v 43 |y 1993 |
| 999 | C | 5 | |a 10.1016/j.mri.2005.02.003 |9 -- missing cx lookup -- |1 M Bilgen |p 601 - |2 Crossref |u Bilgen M, Al-Hafez B, Malone TM, Smirnova IV (2005) Ex vivo magnetic resonance imaging of rat spinal cord at 9.4 T. Magn Reson Imaging 23:601–605 |t Magn Reson Imaging |v 23 |y 2005 |
| 999 | C | 5 | |2 Crossref |u R Core Team (2016) R: a language and environment for statistical computing. R Foundation for Statistical Computing, Viennas. http://www.R-project.org/ . Accessed 24 Nov 2016 |
| 999 | C | 5 | |a 10.1148/radiol.2231010707 |9 -- missing cx lookup -- |1 JCJ Bot |p 46 - |2 Crossref |u Bot JCJ, Barkhof F, à Nijeholt GL et al (2002) Differentiation of multiple sclerosis from other inflammatory disorders and cerebrovascular disease: value of spinal MR imaging. Radiology 223:46–56 |t Radiology |v 223 |y 2002 |
| 999 | C | 5 | |a 10.1212/WNL.0b013e31827b1a67 |9 -- missing cx lookup -- |1 MH Sombekke |p 69 - |2 Crossref |u Sombekke MH, Wattjes MP, Balk LJ et al (2013) Spinal cord lesions in patients with clinically isolated syndrome: a powerful tool in diagnosis and prognosis. Neurology 80:69–75 |t Neurology |v 80 |y 2013 |
| 999 | C | 5 | |a 10.1212/WNL.62.2.226 |9 -- missing cx lookup -- |1 JCJ Bot |p 226 - |2 Crossref |u Bot JCJ, Barkhof F, Polman CH et al (2004) Spinal cord abnormalities in recently diagnosed MS patients: added value of spinal MRI examination. Neurology 62:226–233 |t Neurology |v 62 |y 2004 |
| 999 | C | 5 | |a 10.1038/jcbfm.2015.72 |9 -- missing cx lookup -- |1 R Schmidt |p 26 - |2 Crossref |u Schmidt R, Seiler S, Loitfelder M (2016) Longitudinal change of small-vessel disease-related brain abnormalities. J Cereb Blood Flow Metab 36:26–39 |t J Cereb Blood Flow Metab |v 36 |y 2016 |
| 999 | C | 5 | |a 10.1016/j.mayocp.2013.11.002 |9 -- missing cx lookup -- |1 DM Wingerchuk |p 225 - |2 Crossref |u Wingerchuk DM, Carter JL (2014) Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin Proc 89:225–240 |t Mayo Clin Proc |v 89 |y 2014 |
| 999 | C | 5 | |a 10.1038/nrneurol.2016.21 |9 -- missing cx lookup -- |1 A Winkelmann |p 217 - |2 Crossref |u Winkelmann A, Loebermann M, Reisinger EC et al (2016) Disease-modifying therapies and infectious risks in multiple sclerosis. Nat Rev Neurol 12:217–233 |t Nat Rev Neurol |v 12 |y 2016 |
| 999 | C | 5 | |1 JM Honce |y 2015 |2 Crossref |u Honce JM, Nagae L, Nyberg E (2015) Neuroimaging of natalizumab complications in multiple sclerosis: PML and other associated entities. Mult Scler Int 2015:809252 |
| 999 | C | 5 | |a 10.1001/jamaneurol.2014.3537 |9 -- missing cx lookup -- |1 DL Rotstein |p 152 - |2 Crossref |u Rotstein DL, Healy BC, Malik MT et al (2015) Evaluation of no evidence of disease activity in a 7-year longitudinal multiple sclerosis cohort. JAMA Neurol 72:152–158 |t JAMA Neurol |v 72 |y 2015 |
| 999 | C | 5 | |a 10.1177/1352458512442754 |9 -- missing cx lookup -- |1 K Weier |p 1560 - |2 Crossref |u Weier K, Mazraeh J, Naegelin Y et al (2012) Biplanar MRI for the assessment of the spinal cord in multiple sclerosis. Mult Scler J 18:1560–1569 |t Mult Scler J |v 18 |y 2012 |
| 999 | C | 5 | |a 10.1212/WNL.0b013e3181cec45c |9 -- missing cx lookup -- |1 X Montalban |p 427 - |2 Crossref |u Montalban X, Tintore M, Swanton J et al (2010) MRI criteria for MS in patients with clinically isolated syndromes. Neurology 74:427–434 |t Neurology |v 74 |y 2010 |
| 999 | C | 5 | |a 10.1212/WNL.0b013e31820d8b1d |9 -- missing cx lookup -- |1 DT Okuda |p 686 - |2 Crossref |u Okuda DT, Mowry EM, Cree BAC et al (2011) Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 76:686–692 |t Neurology |v 76 |y 2011 |
| 999 | C | 5 | |a 10.1001/jamaneurol.2015.0993 |9 -- missing cx lookup -- |1 R Schlaeger |p 897 - |2 Crossref |u Schlaeger R, Papinutto N, Zhu AH et al (2015) Association between thoracic spinal cord gray matter atrophy and disability in multiple sclerosis. JAMA Neurol 72:897–904 |t JAMA Neurol |v 72 |y 2015 |
| 999 | C | 5 | |a 10.1002/ana.24241 |9 -- missing cx lookup -- |1 R Schlaeger |p 568 - |2 Crossref |u Schlaeger R, Papinutto N, Panara V et al (2014) Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol 76:568–580 |t Ann Neurol |v 76 |y 2014 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|
guest ::